Taiwan FDA registration c75fe4e9d8e99ae6dd4f278dacc6ed93
KatiaTM hiproprotein antibody detection panel
TW: 卡蒂雅TM 組織蛋白抗體檢測試劑組
Taiwan·Risk Class 2·TRINITY BIOTECH USA·Registered Aug 15, 2006 – Aug 15, 2011CancelledRegistration details
- Analysis ID
- c75fe4e9d8e99ae6dd4f278dacc6ed93
- Customs Code
- DHA00601728007
Company information
- Manufacturer
- TRINITY BIOTECH USA
- Manufacturer Country
- United States
- Authorized Representative
- GRAND MARQUIS CO., LTD.
Product details
- Intended Use
- Enzyme immunosorption assay was used to semi-quantitatively detect tissue protein antibodies in human serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5100 抗核抗體免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Aug 15, 2006
- Expiry Date
- Aug 15, 2011
- Cancellation Date
- Nov 27, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for KatiaTM hiproprotein antibody detection panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c75fe4e9d8e99ae6dd4f278dacc6ed93 and manufactured by TRINITY BIOTECH USA. The authorized representative in Taiwan is GRAND MARQUIS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices